Sustained Release Matrix Tablets
DESIGN AND DEVELOPMENT OF ORAL SUSTAINED RELEASE MATRIX TABLETS OF DIDANOSINE
7
DESIGN AND CHARACTERIZATION OF DONEPEZIL HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLETS
11
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF PIOGLITAZONE
22
Formulation and evaluation of lornoxicam of sustained release matrix tablets
7
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NATEGLINIDE
7
Design and Evaluation of HPMC and Xanthan Gum-Based Sustained Release Matrix Tablets of Theophylline
7
DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LORNOXICAM
12
Formulation and Evaluation of Sustained Release Matrix Tablets of Venlafaxine Hydrochloride
168
FORMULATION AND EVALUATION OF INDAPAMIDE SUSTAINED RELEASE MATRIX TABLETS
5
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF RANOLAZINE
6
Formulation and Evaluation of Nitazoxanide Sustained-Release Matrix Tablets
9
FORMULATION AND EVALUATION OS SUSTAINED RELEASE MATRIX TABLETS OF GLIBENCLAMIDE
15
Formulation and Evaluation of Sustained Release Matrix Tablets of Zidovudine
9
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF CAPTOPRIL
6
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN USING NATURAL POLYMER
12
Formulation and Evaluation of Sustained Release Matrix Tablets of Quetiapine Fumarate
5
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF TAPENTADOL HCL
14
FORMULATION AND INVITRO EVALUATION OF MESALAZINE SUSTAINED RELEASE MATRIX TABLETS
17
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LOSARTAN POTASSIUM
7
Formulation and evaluation of pioglitazone sustained release matrix tablets
7